Item 1.01 Entry into a Material Definitive Agreement.
Cytta Corp./Doctor Direct Inc. and 59 Souls Inc. Agreement for a Rapid Application Development Prototype Project for a Global Mobile Health Chronic Care Platform Dated July 12
th
, 2016
On July 12
th
, 2016 Cytta Corp/Doctor Direct Inc. and 59 Souls Inc., a Digital design and technology consulting firm, of New York, NY entered into a joint venture agreement for a
Rapid Application Development Prototype Project for a Global Mobile Health Chronic Care Platform.
59 Souls Inc., through its CEO Daniel Johnson agreed, to create, revise, upgrade, enhance, redesign and rewrite all of the proprietary software code for the Cytta/Doctor Directs managed care or Dr. Directed portion of the full EvrCare remote medical monitoring technology and platform.
Cytta/Doctor Directs managed care or Dr. Directed medical remote monitoring system version 1.6 has been fully operational for the last few years with extremely successful live patient clinical trials being conducted by the Heritage Provider Network of California in 2011 and 2012. However, advances in smartphones, IoT, the Cloud, programs and programming languages required that a completely updated Dr. Directed version 2.0 be created. Because of 59 Souls belief in, and commitment to our vision and Project it was agreed that 59 Souls would receive remuneration in both cash and stock for the successful completion of the project.
The Cytta/Doctor Directs EvrCare platform has two primary silos or vertical markets. The Managed Care, or Dr. Directed remote monitoring market, is designed for Doctors to prescribe medical grade peripherals for chronically ill patients and monitor them in real-time. Our Dr. Directed system is fully HIPAA compliant and is billable by the Physician monthly using existing Health and Human Services (HHS) billing CPT codes. This is the first market that we will be marketing this proprietary Dr. Directed technology into.
The second silo or vertical market of the EvrCare platform is the Consumer health and wellness vertical which allows family members or non-physician caregivers to monitor their loved ones in real-time using any and all Bluetooth monitoring devices for a small fee. Additionally, consumers will also be able to utilize our technology to automatically collect, monitor and review any and all Bluetooth data their existing devices are producing at no cost.
This second portion of our full EvrCare model will be built out by 59 Souls under our next development contract and will complete the EvrCare platform. These plans include transposing all portals and 3
rd
party applications into a SaaS application (software as service) and a SaaS recurring business model, with three levels of service. An iOS version will be in development as well, starting Q1, 2017.
2
59 Souls has finalized version 2.11 of the Dr. Directed portion of Cyttas EvrCare platform including creating, revising, upgrading, enhancing and rewriting all the proprietary software code for the:
•
VeriSmartPhone App
Proprietary app that downloads into Android phones (IOS to follow) that automatically picks up Bluetooth readings from medical peripherals (BP etc.) and interprets the reading and automatically sends the data and alerts via cellular or WiFi (and satellite if necessary).
•
Patient Platform
is a web based platform where each Patients data is stored and displayed and available as an EHR (Electronic Health Record) for patients, Doctors and caregivers. This data is readily available to other EHR programs and applications.
•
Doctor Dashboard
is our proprietary program for the Doctors office computers (and later Cloud) allowing the Doctor to monitor all patients and their readings and alerts in real-time. Doctor and patient may communicate through voice, data and/or video conference
•
Administrator Platform
is our web based platform designed for Healthcare facilities, Medical Groups, and Provider Networks and their registered users to register and administer patients on the Dr. Directed portion of the EvrCare network.
Through the period from July 12
th
, 2016 forward 59 Souls development team and the Company worked continuously to create a completely updated version of our Dr. Directed remote monitoring vision. The effort by 59 Souls and the team was extraordinary and final Dr. Directed product exceeded our expectations.
59 Souls delivered the new remote HIPAA compliant Dr. Directed medical software platform, on December 12
th
, 2016. Version 2.0 and 2.11 (incorporating revisions to 2.0) of the Dr. Directed portion of the EvrCare technology has now been migrated from MySQL to Amazons AWS services, running on Oracle database servers, meeting all HIPAA security requirements and has been escrowed and is fully and securely under Cytta control.
Cytta/Doctor Direct is now ready to market, sell and deploy the Dr. Directed portion of their EvrCare platform and to move onto to the second development phase of their full EvrCare platform in the near future. Additionally, Mr. Daniel Johnson, CEO and Chairman of 59 Souls has agreed to join the Cytta team as our Director of Technical Development.
3